Combining Machine Learning and Nanobiosensors for Improving Lung Cancer Detection

  • سال انتشار: 1403
  • محل انتشار: دومین سمپوزیوم منطقه ای نوآوری در علم وفناوری
  • کد COI اختصاصی: RESIST02_039
  • زبان مقاله: انگلیسی
  • تعداد مشاهده: 138
دانلود فایل این مقاله

نویسندگان

Shakiba Nazemian

Department of Pathobiology, Faculty of Veterinary Medicine, Ferdowsi University of Mashhad, Mashhad, Iran

Soheil Sadr

Department of Pathobiology, Faculty of Veterinary Medicine, Ferdowsi University of Mashhad, Mashhad, Iran

Ashkan Hajjafari

Department of Pathobiology, Faculty of Veterinary Specialized Science, Science, and Research Branch, Islamic Azad University, Tehran, Iran

Khashayar Hajjafari

Medical Doctor, Shahid Bahonar University of Kerman, Kerman, Iran

Abbas Rahdar

Department of Physics, University of Zabol, Zabol, Iran

Mahdis Khajehmohammadi

Department of Basic Sciences, Faculty of Veterinary Medicine, Baft branch, Islamic Azad University, Baft, Iran

چکیده

Lung cancer is one of the most prevalent types of cancer in the world, and its clinical prognosis and early detection are of great importance. With recent advances in artificial intelligence and nanotechnology, combining machine learning (ML) and nanobiosensors has been considered a novel approach for diagnosing and monitoring lung cancer. Hence, the current review aims to examine the combination of these two technologies for lung cancer diagnosis and explores its potential and challenges. ML can identify patterns associated with lung cancer with its capabilities in processing complex data and simulating predictive models. Nanobiosensors, on the other hand, can detect biological changes at the molecular and cellular levels with high sensitivity. These two technologies allow for more accurate, faster, and non-invasive lung cancer diagnosis. In addition, using these two technologies simultaneously could help identify more advanced changes in the disease, even before clinical symptoms become apparent. In conclusion, combining machine learning and nanobiosensors offers a novel and efficient approach to lung cancer diagnosis that can significantly increase the accuracy of diagnosis and prognosis.

کلیدواژه ها

Lung cancer, Nanotechnology, Nanobiosensors, Artificial intelligence

مقالات مرتبط جدید

اطلاعات بیشتر در مورد COI

COI مخفف عبارت CIVILICA Object Identifier به معنی شناسه سیویلیکا برای اسناد است. COI کدی است که مطابق محل انتشار، به مقالات کنفرانسها و ژورنالهای داخل کشور به هنگام نمایه سازی بر روی پایگاه استنادی سیویلیکا اختصاص می یابد.

کد COI به مفهوم کد ملی اسناد نمایه شده در سیویلیکا است و کدی یکتا و ثابت است و به همین دلیل همواره قابلیت استناد و پیگیری دارد.